Trevena Announces Partial Exercise of Underwriters' Overallotment Option
March 06, 2014 at 17:04 PM EST
Trevena (NASDAQ: TRVN), a clinical stage pharmaceutical company involved in the discovery and development of G protein coupled receptor ...